The Pharma Legal Handbook: South Africa

South Africa is the largest pharmaceutical market in sub-Saharan Africa and the most commercially sophisticated, with a well-developed private healthcare sector and a significant public health system. The South African Health Products Regulatory Authority (SAHPRA) manages product registration and post-market surveillance, having taken over from the former MCC.

South Africa operates a single exit price system for pharmaceutical products, with the annual price increase mechanism and the transparent pricing regulations creating a distinctive pricing environment. The public procurement market, managed through the National Department of Health and provincial tender processes, is a major channel for companies with products on the essential drugs list.

The Pharma Legal Handbook: South Africa provides comprehensive guidance on pharmaceutical regulation in South Africa, covering SAHPRA product registration, single exit pricing, public procurement frameworks, clinical trial requirements, pharmacovigilance obligations, manufacturing standards, marketing rules, and intellectual property protection.